In the context of increasingly stringent global pharmaceutical regulations, choosing a licensed Pharmaceutical Distributor in Hong Kong with verified wholesale and export qualifications means selecting

In 1852, French physician Duchenne described boys with progressive muscle weakness whose enlarged calves were replaced by fat and fibrous tissue, leading to death from

In today’s increasingly competitive global pharmaceutical landscape, choosing a reputable pharmaceutical wholesaler has become a critical strategic decision for pharmaceutical companies, healthcare institutions, and medical

Lung cancer remains the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of cases. Thanks to advances

Before the advent of targeted therapy, ALK-positive advanced non-small cell lung cancer (NSCLC) typically progressed rapidly, with a high incidence of brain metastases and limited

Epidermal growth factor receptor EGFR–targeted drugs represent a cornerstone in the treatment of advanced non–small cell lung cancer (NSCLC) harboring EGFR gene mutations. EGFR mutations

In recent years, rare disease treatment has rapidly risen from a niche medical issue to one of the most active core areas of global pharmaceutical